Research Topics
| Kenneth G CastroSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
Bridging implementation, knowledge, and ambition gaps to eliminate tuberculosis in the United States and globallyKenneth G Castro
Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop E10, Atlanta, GA 30333, USA
Emerg Infect Dis 17:337-42. 2011..To accelerate progress against the global effects of disease caused by TB and achieve its elimination, we must bridge 3 key gaps in implementation, knowledge, and ambition...
Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infectionKashef Ijaz
Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA 30333, USA
Clin Infect Dis 42:346-55. 2006..Severe liver injuries were attributed to the rifampin and pyrazinamide (RZ) regimen after it was recommended for treating latent tuberculosis infection. Implicating RZ as the likeliest cause required excluding alternative causes...- HIV infection and multidrug-resistant tuberculosis: the perfect stormCharles D Wells
Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Infect Dis 196:S86-107. 2007..The global human immunodeficiency virus (HIV) infection epidemic has caused explosive increases in TB incidence and may be contributing to increases in MDR-TB prevalence... 
Extensively drug-resistant tuberculosis in the United States, 1993-2007N Sarita Shah
Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop E 10, Atlanta, GA 30333, USA
JAMA 300:2153-60. 2008..Worldwide emergence of extensively drug-resistant tuberculosis (XDR-TB) has raised global public health concern, given the limited therapy options and high mortality...- Unexpected decline in tuberculosis cases coincident with economic recession - United States, 2009Carla A Winston
Division of Tuberculosis Elimination, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
BMC Public Health 11:846. 2011..To address the unexpected decline, we examined trends from multiple sources on TB treatment initiation, medication sales, and laboratory and genotyping data on culture-positive TB... - Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993-2004Rachel Albalak
Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA 30323, USA
Arch Intern Med 167:2443-52. 2007..To our knowledge, this is the first assessment of trends in tuberculosis (TB)/human immunodeficiency virus (HIV) comorbidity in the United States based on national TB surveillance data... - Tuberculosis among foreign-born persons in the United States: achieving tuberculosis eliminationKevin P Cain
Centers for Disease Control and Prevention, 1600 Clifton Road, MS E 10, Atlanta, GA 30333, USA
Am J Respir Crit Care Med 175:75-9. 2007..Current guidelines recommend targeting only foreign-born persons who entered the United States within the previous 5 yr for LTBI testing... - Improved program activities are associated with decreasing tuberculosis incidence in the United StatesMark N Lobato
Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop E 10, Atlanta, GA 30333, USA
Public Health Rep 121:108-15. 2006..Based on these results, we propose that further improvements in these activities will accelerate the decline of TB in the United States... - National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infectionPeter D McElroy
Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, GA 30333, USA
Clin Infect Dis 41:1125-33. 2005..We estimated rates of rifampin-pyrazinamide-associated liver injury and compared these with historical rates for isoniazid... - Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000Diane E Bennett
Centers for Disease Control and Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, Georgia, USA
Am J Respir Crit Care Med 177:348-55. 2008..The goal for tuberculosis (TB) elimination in the United States is a TB disease incidence of less than 1 per million U.S. population by 2010, which requires that the latent TB infection (LTBI) prevalence be less than 1% and decreasing... - 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trialTaraz Samandari
Botswana USA Partnership BOTUSA, Gaborone and Francistown, Botswana
Lancet 377:1588-98. 2011..We aimed to assess effectiveness of extended isoniazid therapy... - New guidelines about latent tuberculosis infection in children and adolescents: a welcome advancementLisa J Nelson
Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, MS E-10, Atlanta, GA 30333, USA
Pediatrics 114:1084-6. 2004 - Challenges and controversies in defining totally drug-resistant tuberculosisPeter Cegielski
Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Emerg Infect Dis 18:e2. 2012..Labeling TB strains as totally drug resistant might lead providers to think infected patients are untreatable. These challenges must be addressed before defining a new category for highly drug-resistant TB... - Epidemiology of tuberculosis in the United StatesEileen Schneider
Division of Tuberculosis and Elimination, Centers for Disease Control and Prevention, 1600 Clifton Road, MS E 10, Atlanta, GA 30333, USA
Clin Chest Med 26:183-95, v. 2005..Key challenges remain, and efforts must focus on identifying and targeting interventions for high-risk populations, active involvement in the global effort against tuberculosis, developing new tools, and maintaining adequate resources... - Epidemiology of tuberculosisMichael F Iademarco
United States Public Health Service, Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, GA 30333, USA
Semin Respir Infect 18:225-40. 2003..This report describes the global epidemiology of TB and the epidemiology in the United States, and outlines future challenges to the elimination of TB in the United States... - [Tuberculosis elimination in the United States; why, how, and what will it take?]Kenneth G Castro
Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Kekkaku 83:93-100. 2008..quot;.. - Epidemic Intelligence Service investigations of respiratory illness, 1946-2005Stephen C Hadler
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA 30333, USA
Am J Epidemiol 174:S36-46. 2011..The outbreak investigations constitute a wealth of prevention experience and provide the basis for recommendations to mitigate outbreaks and reduce future risks... - Rationale and methods for the National Tuberculosis Genotyping and Surveillance NetworkKenneth G Castro
Division of Tuberculosis Elimination, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Emerg Infect Dis 8:1188-91. 2002..Genotyping proved a useful adjunct to investigations of outbreaks, unusual clusters, and laboratory cross-contamination...